Research
Hormonal
Current data indicate a rapid shift from single-pathway interventions toward multimodal therapeutic strategies in obesity and type 2 diabetes.
Practitioners should consider multimodal approaches as the future direction for treating obesity and type 2 diabetes.
StrongSupportsmedium confidence
Current data indicate a rapid shift from single-pathway interventions toward multimodal therapeutic strategies in obesity and type 2 diabetes.
Why this rating
The claim is based on a review of recent clinical data.
Source
Beyond <scp>GLP</scp> ‐1 Monotherapy: Novel Multi‐Agonists, Amylin Analogues, and Combination Strategies in Obesity and Type 2 Diabetes
Mikhail Khachaturov et al. · Diabetes Obesity and Metabolism · 2026
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →